Nasal drug products present significant opportunities to deliver drugs topically or systemically via innovative formulations or device designs. These products vary in device type and formulation (solution / suspension) however can be an ideal platform for the delivery of both small and large molecules.

In this white paper, Teresa Iley, Intertek’s Director of Pharmaceutical Development & Manufacturing, introduces nasal drug products including the benefits of this platform, regulatory considerations and approaches to overcome the challenges of development for this product type.

Please complete this form to download our white paper